AbbVie Inc (NYSE:ABBV) reported that the European CHMP of the European Medicines Agency has granted a promising opinion suggesting marketing approval of MAVIRET™, an investigational, pan-genotypic...
In the last trading session, the stock price of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) traded in a narrow range, only to close marginally in green. Latest...
Q BioMed Inc (OTCMKTS:QBIO) reported that Christopher Manuele will join commercialization team of the Strontium 89 Chloride. Manuele is a results-driven, innovative executive with 35 years...
Vitality Biopharma Inc (OTCMKTS:VBIO) a firm looking into the innovation of Hemps prodrug pharmaceuticals, and unveiling the usefulness of Hemps for the inflammatory and neurological problems,...
Latest R&D in the medical cannabis market is assisting industry leaders list breakthroughs and notable discoveries for advancing new patents and treatments for numerous applications aiming...
THC Biomed International Ltd. (OTCMKTS:THCBF) has obtained an order from Germany to export Dried Marihuana. The company has commenced the process to fulfill regulatory guidelines to...
Axim Biotechnologies Inc (OTCMKTS:AXIM) reported that it has filed with the USPTO a patent of invention that comprises a chewing gum composition having controlled release of...
CV Sciences Inc (OTCMKTS:CVSI) reported that the June 1 presentation from CFO Joseph Dowling is available for on-demand broadcasting at VirtualInvestorConferences.com. The presentation is made accessible...
Q BioMed Inc (OTCMKTS:QBIO) and ASDERA LLC reported a licensing deal that offers Q Biomed with the global rights to ASDERA’s ‘ASD-002’, which is being advanced...
InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) reported the closing of its previously posted public offering. As per this offering, the firm issued 12.788 million units at a price...